Research & Development



  雲瑯歡喜的道︰“總要做出決斷的,小蟲做了,盡管孟大會非常的傷心。”   蒙查自草叢里拔出一顆蒲公英丟進狗子的背簍問道。国内超碰免费公开视频 會被擺上台面,到時候,會有很多人很樂意見到雲氏與黃氏斗得頭破血流。”哥哥干|哥哥干,哥也爱,俺去也,哥哥去,狠狠撸,妹妹干   劉陵笑道︰“還真是雲氏做派,先傳達你家主子的聲音,而後才傳達陛下的旨意,就這一條,只要傳到漢地,你家主子就會死無葬身之地!”   甦稚哦了一聲就不說話了。超碰在线caoporn自拍   雲瑯怒道︰“死的是你祖母,你怎麼能說出這樣的話,快些把你的馬鞍子去掉,騎著光背馬,要跑的比我還要快才成,敢再笑一下,小心母親剝了你的皮。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo